Katakura Industries (3001) Q4 2025 earnings summary

Executive summary

• Revenue increased 3.1% year-over-year to ¥40,652 million, driven by growth in machinery and real estate, offsetting declines in pharmaceuticals and textiles.

• Operating income rose 42.0% to ¥5,855 million, and net income attributable to shareholders surged 63.5% to ¥5,763 million, aided by fixed asset sales.

• All major business segments except pharmaceuticals and textiles posted higher operating profits, with machinery showing the strongest rebound.

Financial highlights

• Gross margin remained stable as cost controls offset higher raw material prices.

• Operating margin improved to 14.4% from 10.5% year-over-year.

• Cash and equivalents at year-end increased 34.4% to ¥12,387 million.

• Equity ratio rose to 63.8%, reflecting strengthened financial position.

• EPS increased to ¥180.73 from ¥107.72 year-over-year.

Outlook and guidance

• FY2026 revenue is forecast at ¥41,100 million (+1.1%), with operating income at ¥5,500 million (−6.1%) and net income at ¥5,200 million (−9.8%).

• Management expects continued cost pressures from inflation and currency, but will pursue structural reforms and growth investments, especially in functional fibers.

• Dividend forecast maintained at ¥60 per share for FY2026.